Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LMNA | P02545 | 2/20 | 0.37 |
| ▸ | MAPK1 | P28482 | 2/20 | 0.37 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.37 |
| ▸ | THRB | P10828 | 1/20 | 0.37 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.37 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.34 |
| ▸ | POLB | P06746 | 1/20 | 0.34 |
| ▸ | MAPT | P10636 | 1/20 | 0.30 |
| ▸ | TSHR | P16473 | 1/20 | 0.30 |
| ▸ | RECQL | P46063 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL8241582 | 1.00 | LMNA (0.37) | LMNAMAPK1ALDH1A1THRBALOX15 | |
| SCHEMBL9862355 | 1.00 | LMNA (0.37) | LMNAMAPK1ALDH1A1THRBALOX15 | |
| SCHEMBL221185 | 1.00 | LMNA (0.37) | LMNAMAPK1ALDH1A1THRBALOX15 | |
| SCHEMBL9862354 | 1.00 | LMNA (0.37) | LMNAMAPK1ALDH1A1THRBALOX15 | |
| Water SCHEMBL890485 | 0.98 | ALDH1A1 (0.36) | LMNAMAPK1ALDH1A1THRBALOX15 | |
| Alcohol SCHEMBL11674015 | 0.92 | ALDH1A1 (0.33) | LMNAMAPK1ALDH1A1THRBALOX15 | |
| SCHEMBL1868393 | 0.77 | — | — | |
| SCHEMBL11504897 | 0.75 | LMNA (0.32) | LMNAMAPK1MAPTTSHRRECQL | |
| SCHEMBL13400151 | 0.74 | — | — | |
| SCHEMBL9053737 | 0.74 | LMNA (0.35) | LMNASMN1; SMN2RECQL |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 76 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20220242809-A1 | METHODS FOR ISOLATING ESSENTIAL OILS, PHYTOCHEMICALS AND PHARMACEUTICALLY ACTIVE COMPONENTS FROM BIOMASS AND RECONSTITUTING SYNTHETIC FORMULATIONS COMPRISING SAME | ATLAS HEMP COMPANY LLC (US) | 2022-08-04 | — | — | US | claimed |
| US-11261477-B2 | Glycosylation modification of bioactive compounds and drugs by plant glycosyltransferases (UGTs) | UNIVERSITY OF NORTH TEXAS (US) | 2022-03-01 | — | — | US | claimed |
| US-12564602-B2 | Contact lens treating solution | BAUSCH + LOMB IRELAND LIMITED (IE) | 2026-03-03 | — | — | US | disclosed |
| US-20250344733-A1 | FLAVOR NANOEMULSIONS FOR BEVERAGE AND PERSONAL CARE APPLICATIONS | FIRMENICH SA (CH) | 2025-11-13 | — | — | US | disclosed |
| EP-4638677-A1 | CONTACT LENS TREATING SOLUTION | Bausch + Lomb Ireland Limited (IE) | 2025-10-29 | — | — | EP | disclosed |
| CN-120077121-A | Contact lens treatment solution | 博士伦爱尔兰有限公司 | 2025-05-30 | — | — | CN | disclosed |
| US-20250154289-A1 | GLYCOPHOSPHOLIPID POLYMERIC NETWORK AND USE THEREOF | JPMORGAN CHASE BANK, N.A., AS SUCCESSOR AGENT | 2025-05-15 | — | — | US | disclosed |
| EP-4291157-B1 | FRAGRANCE DELIVERY COMPOSITIONS | TAMINCO BV (BE) | 2025-03-19 | — | — | EP | disclosed |
| US-12227598-B2 | Glycophospholipid polymeric network and use thereof | BAUSCH & LOMB INCORPORATED (US) | 2025-02-18 | — | — | US | disclosed |
| EP-4503939-A1 | FLAVOR NANOEMULSIONS FOR BEVERAGE AND PERSONAL CARE APPLICATIONS | Firmenich SA (CH) | 2025-02-12 | — | — | EP | disclosed |
| CN-119317358-A | Flavor nanoemulsions for beverage and personal care applications | 弗门尼舍有限公司 | 2025-01-14 | — | — | CN | disclosed |
| US-6492086-B1 | TERPOLYMERS OF M- AND P-HYDROXYSTYRENE AND ACRYLIC ESTER OF ALKYLADAMANTYL, ETHYLFENCYL, TRICYCLO DECANYL, OR PINANYL GROUP; IMAGING AT SHORT WAVELENGTHS; HIGH RESOLUTION RELIEF IMAGES | SHIPLEY COMPANY, L.L.C. | 2002-12-10 | — | — | US | disclosed |
| WO-2002069038-A2 | NOVEL POLYMERS AND PHOTORESIST COMPOSITIONS COMPRISING SAME | SHIPLEY COMPANY, L.L.C. (US) | 2002-09-06 | — | — | WO | disclosed |
| WO-2002069040-A1 | NOVEL POLYMERS, PROCESSES FOR POLYMER SYNTHESIS AND PHOTORESIST COMPOSITIONS | SHIPLEY COMPANY, LLC (US) | 2002-09-06 | — | — | WO | disclosed |
| EP-1210650-A1 | POLYMERS CONTAINING OXYGEN AND SULFUR ALICYCLIC UNITS AND PHOTORESIST COMPOSITIONS COMPRISING SAME | Shipley Company LLC (US) | 2002-06-05 | — | — | EP | disclosed |
| WO-2001086353-A1 | POLYMERS CONTAINING OXYGEN AND SULFUR ALICYCLIC UNITS AND PHOTORESIST COMPOSITIONS COMPRISING SAME | SHIPLEY COMPANY, L.L.C. (US) | 2001-11-15 | — | — | WO | disclosed |
| US-6306554-B1 | PHOTORESIST COMPOSITION COMPRISING PHOTOACTIVE COMPONENT AND POLYMER THAT COMPRISES A PHOTOACID-LABILE MOIETY AND STRUCTURE CONTAINING OXYGEN AND/OR SULFUR ALICYCLIC UNITS AND CARBON ALICYCLIC UNITS | SHIPLEY COMPANY, L.L.C. | 2001-10-23 | — | — | US | disclosed |
| EP-1128213-A2 | Photoresist compositions comprising novel copolymers | Shipley Company LLC (US) | 2001-08-29 | — | — | EP | disclosed |
| EP-1091249-A1 | Copolymers having nitride and alicyclic leaving groups and photoresist compositions comprising same | Shipley Company LLC (US) | 2001-04-11 | — | — | EP | disclosed |
| EP-1091250-A1 | Copolymers having phenol groups and alicyclic groups and photoresist compositions comprising same | Shipley Company LLC (US) | 2001-04-11 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20250154289-A1 | GLYCOPHOSPHOLIPID POLYMERIC NETWORK AND USE THEREOF | ALG1, CSGALNACT1, FUT6 | LMNA 2560/4885MAPK1 2507/4885ALDH1A1 4141/4885 |
| US-12564602-B2 | Contact lens treating solution | CRYZ, CUTA, EBPL | LMNA 2163/4885MAPK1 1467/4885ALDH1A1 4554/4885 |
| US-12227598-B2 | Glycophospholipid polymeric network and use thereof | ALG1, CSGALNACT1, FUT6 | LMNA 2560/4885MAPK1 2507/4885ALDH1A1 4141/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.